PK Statistics Studies
A comprehensive study of the Pharmacokinetics (PK) of your drug candidate
PhInc. Modeling pharmacokineticists provide precise analysis of data, whatever the purpose of your pharmacokinetic (PK) studies. PhInc. Modeling covers all PK analysis requirements, including:
- Dose and time linearity studies
- Drug-Drug interactions
- Gender and age impacts on the drug metabolism and pharmacokinetic (DMPK) of drugs
- Impact of hepatic or renal insufficiency on pharmacokinetic
- Bioequivalence studies
Calculations of PK parameters are performed according to standard international definitions. Calculations are then followed by in-depth interpretation of the PK parameters by senior scientists.
PhinC Development team offers the most accurate results mastering the recognized software packages: WinNonlin® and SAS. We can quickly and precisely provide you with all the information needed to answer regulatory questions.
PhInc. Modeling team offers the most accurate results mastering the recognized software packages:
- our frequent interactions with health authorities,
- our knowledge of regulatory submission standards,
- and our command of industry-recognized software: WinNonlin and SAS.
We can quickly and precisely provide you with all the information needed to answer regulatory questions.
Le Clinical Data Interchange Standards Consortium The Clinical Data Interchange Standards Consortium (CDISC) has been in place to streamline the submission of clinical study data.
From now on, PhInc. Modeling can ensure your successful mapping strategy for submitting your PK data in a CDISC compliant format.
Sales sheet and articles
Learn more about
Keep up to date with the latest news
[Webinar] Translational Mechanistic Modeling : Applications for ADCs
PhinC Development is pleased to host an exclusive webinar dedicated to Translational Mechanistic Modeling: Applications for Antibody Drug Conjugates (ADCs). Discover how Model-Informed Drug Development (MIDD) strategies can accelerate and de-risk ADC programs.